• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KINETIC CONCEPTS, INC ACTIV.A.C. ION PROGRESS REMOTE THERAPY MONITORING SYSTEM; OMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KINETIC CONCEPTS, INC ACTIV.A.C. ION PROGRESS REMOTE THERAPY MONITORING SYSTEM; OMP Back to Search Results
Model Number WNDARM
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Skin Irritation (2076)
Event Date 02/29/2020
Event Type  Injury  
Manufacturer Narrative
Unique identifier (udi) # for v.A.C.® granufoam¿ dressing lot number 7171883v009: (b)(4).Based on information provided, it cannot be determined that the alleged hospitalization and infection are related to the activ.A.C.¿ ion progress¿ remote therapy monitoring system.Kci has made multiple unsuccessful attempts to obtain additional clinical information.Device labeling, available in print and online, states: infected wounds should be monitored closely and may require more frequent dressing changes than non-infected wounds, dependent upon factors such as wound conditions, treatment goals.Refer to dressing application instructions (found in v.A.C.® dressing cartons) for details regarding dressing change frequency.As with any wound treatment, clinicians and patients/caregivers should frequently monitor the patient's wound, periwound tissue and exudate for signs of infection, worsening infection, or other complications.Some signs of infection are fever, tenderness, redness, swelling, itching, rash, increased warmth in the wound or periwound area, purulent discharge or strong odor.Infection can be serious, and can lead to complications such as pain, discomfort, fever, gangrene, toxic shock, septic shock and/or fatal injury.Some signs or complications of systemic infection are nausea, vomiting, diarrhea, headache, dizziness, fainting, sore throat with swelling of the mucus membranes, disorientation, high fever, refractory and/or orthostatic hypotension or erythroderma (a sunburn-like rash).If there are any signs of the onset of systemic infection or advancing infection at the wound site, contact the treating physician immediately to determine if v.A.C.® therapy should be discontinued.Precautions the v.A.C.® therapy system will not be effective in addressing complications associated with the following: ischemia to the incision or incision area.Untreated or inadequately treated infection.Inadequate hemostasis of the incision.Cellulitis of the incision area.
 
Event Description
On 03-mar-2020, the following information was reported to kci by the patient: on 29-feb-2020, the activ.A.C.¿ ion progress¿ remote therapy monitoring system was removed allegedly due to irritation and pus noted around the wound and the patient was admitted to the hospital for a couple of days.A device evaluation for activ.A.C.¿ ion progress¿ remote therapy monitoring system is currently pending completion.A device history record review for v.A.C.® granufoam¿ dressing lot number 7171883v009 is currently pending completion.
 
Manufacturer Narrative
Additional information for v.A.C.® granufoam¿ dressing lot number 7171883v009: section d4 expiration date: 30-sep-2022.Section h4 device manufacture date: 22-oct-2019.Based on the additional information obtained regarding the device and the v.A.C.® granufoam¿ dressing, kci's assessment remains the same: it cannot be determined that the alleged hospitalization and infection are related to the activ.A.C.¿ ion progress¿ remote therapy monitoring system.Mdr-3009897021-2020-0142 submitted on 02-apr-2020 reported the following: g1: email:(b)(4).Correction: g1: email:(b)(4).
 
Event Description
On 11-feb-2020, the device was tested per quality control procedure by kci service center, and the unit passed the quality control checks and met specifications.On (b)(6) 2020, the device was placed with the patient.On 10-apr-2020, the device was tested per quality control procedure by kci quality engineering and the unit passed the quality control checks and met specifications.Inspection and testing of the device did not reveal any evidence of an operational malfunction with the unit.On 17-apr-2020, a device history record review for v.A.C.® granufoam¿ dressing lot number 7171883v009 was completed.All end release testing of product and packaging met specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIV.A.C. ION PROGRESS REMOTE THERAPY MONITORING SYSTEM
Type of Device
OMP
Manufacturer (Section D)
KINETIC CONCEPTS, INC
san antonio, tx
MDR Report Key9919248
MDR Text Key188565437
Report Number3009897021-2020-00142
Device Sequence Number1
Product Code OMP
UDI-Device Identifier00849554005600
UDI-Public0100849554005600
Combination Product (y/n)N
PMA/PMN Number
K063692
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberWNDARM
Device Lot Number7171883V009
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/06/2020
Initial Date Manufacturer Received 03/03/2020
Initial Date FDA Received04/02/2020
Supplement Dates Manufacturer Received04/17/2020
Supplement Dates FDA Received05/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age51 YR
-
-